Comparative Analysis of Circulating Levels of SARS-CoV-2 Antibodies and Inflammatory Mediators in HealthcareWorkers and COVID-19 Patients

Detalhes bibliográficos
Autor(a) principal: Pinto, Luzia Maria de Oliveira
Data de Publicação: 2022
Outros Autores: Solórzano, Victor Edgar Fiestas, Martins, Maria de Lourdes, Santos, Caroline Fernandes, Damasco, Paula Hesselberg, Siqueira, Marilda Agudo Mendonça Teixeira de, Dias, Helver Gonçalves, Pauvolid-Corrêa, Alex, Damasco, Paulo Vieira, Azeredo, Elzinandes Leal de
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da FIOCRUZ (ARCA)
Texto Completo: https://www.arca.fiocruz.br/handle/icict/56423
Resumo: Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Imunologia Viral. Rio de Janeiro, RJ, Brasil.
id CRUZ_60a5aa0376521791c69d3385fd057c7f
oai_identifier_str oai:www.arca.fiocruz.br:icict/56423
network_acronym_str CRUZ
network_name_str Repositório Institucional da FIOCRUZ (ARCA)
repository_id_str 2135
spelling Pinto, Luzia Maria de OliveiraSolórzano, Victor Edgar FiestasMartins, Maria de LourdesSantos, Caroline FernandesDamasco, Paula HesselbergSiqueira, Marilda Agudo Mendonça Teixeira deDias, Helver GonçalvesPauvolid-Corrêa, AlexDamasco, Paulo VieiraAzeredo, Elzinandes Leal de2023-01-10T17:33:09Z2023-01-10T17:33:09Z2022PINTO, Luzia Maria de Oliveira et al. Comparative Analysis of Circulating Levels of SARS-CoV-2 Antibodies and Inflammatory Mediators in Healthcare Workers and COVID-19 Patients. Viruses, v. 14, 455, p. 1 - 19, Feb. 2022.1999-4915https://www.arca.fiocruz.br/handle/icict/5642310.3390/v14030455engMDPISARS-CoV-2COVID-19Profissionais de saúdeAnticorposCitocinaQuimiocinasPacientesBrasilSARS-CoV-2COVID-19Healthcare workersAntibodiesCytokinesChemokinesBrazilPatientsComparative Analysis of Circulating Levels of SARS-CoV-2 Antibodies and Inflammatory Mediators in HealthcareWorkers and COVID-19 Patientsinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleFundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Imunologia Viral. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Imunologia Viral. Rio de Janeiro, RJ, Brasil.Rede Casa Hospital Rio Laranjeiras e Rio Botafogo. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Imunologia Viral. Rio de Janeiro, RJ, Brasil.Universidade Federal Fluminense (UFF). Departamento de Clínica Médica. Niterói, RJ, Brasil.Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Vírus Respiratório e Sarampo. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Imunologia Viral. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Vírus Respiratório e Sarampo. Rio de Janeiro, RJ, Brasil / Department of Veterinary Integrative Biosciences, Texas A&M University, College Station. Texas, USA,Rede Casa Hospital Rio Laranjeiras e Rio Botafogo. Rio de Janeiro, RJ, Brasil / Universidade do Estado do Rio de Janeiro. Faculdade de Ciências Médicas. Rio de Janeiro, RJ, Brasil / Universidade Federal do Estado do Rio de Janeiro. Faculdade de Medicina. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Imunologia Viral. Rio de Janeiro, RJ, Brasil.Advances in knowledge of the pathophysiology of COVID-19 have been acquired; however, the host factors that could explain the mild and severe forms of the disease are not fully understood. Thus, we proposed to evaluate anti-SARS-CoV-2 antibodies and the inflammatory response of different groups of individuals, including healthcare workers (HCW), sick and dead COVID-19 patients and also recovered patients to contribute to this knowledge gap. Our objective is to relate the clinical evolution of these individuals with the level of detection and functionality of specific antibodies and with the production of inflammatory mediators. As main findings, IgA and IgG anti-SARS-CoV-2 were detected in asymptomatic HCW. IFN- and TNF- levels were higher in symptomatic HCWs than patients with COVID-19 and those who died. Patients who died had higher levels of IL-6, IL-10, and CCL2/MCP-1. We found an imbalance between antiviral and pro-inflammatory mediators in the groups, in which IFN- and TNF- seem to be more associated with protection and IL-6 and CCL2/MCP-1 with pathology. Our work is pioneering the Brazilian population and corroborates data from people from other countries.info:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZLICENSElicense.txtlicense.txttext/plain; charset=utf-82991https://www.arca.fiocruz.br/bitstream/icict/56423/1/license.txt5a560609d32a3863062d77ff32785d58MD51ORIGINALLuziaPinto_AlexCorrea_etal_IOC_2022.pdfLuziaPinto_AlexCorrea_etal_IOC_2022.pdfapplication/pdf1932789https://www.arca.fiocruz.br/bitstream/icict/56423/2/LuziaPinto_AlexCorrea_etal_IOC_2022.pdfc0938d3de6aa54a012207f05d31e884dMD52icict/564232023-09-04 11:10:51.824oai:www.arca.fiocruz.br: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ório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352023-09-04T14:10:51Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)false
dc.title.en_US.fl_str_mv Comparative Analysis of Circulating Levels of SARS-CoV-2 Antibodies and Inflammatory Mediators in HealthcareWorkers and COVID-19 Patients
title Comparative Analysis of Circulating Levels of SARS-CoV-2 Antibodies and Inflammatory Mediators in HealthcareWorkers and COVID-19 Patients
spellingShingle Comparative Analysis of Circulating Levels of SARS-CoV-2 Antibodies and Inflammatory Mediators in HealthcareWorkers and COVID-19 Patients
Pinto, Luzia Maria de Oliveira
SARS-CoV-2
COVID-19
Profissionais de saúde
Anticorpos
Citocina
Quimiocinas
Pacientes
Brasil
SARS-CoV-2
COVID-19
Healthcare workers
Antibodies
Cytokines
Chemokines
Brazil
Patients
title_short Comparative Analysis of Circulating Levels of SARS-CoV-2 Antibodies and Inflammatory Mediators in HealthcareWorkers and COVID-19 Patients
title_full Comparative Analysis of Circulating Levels of SARS-CoV-2 Antibodies and Inflammatory Mediators in HealthcareWorkers and COVID-19 Patients
title_fullStr Comparative Analysis of Circulating Levels of SARS-CoV-2 Antibodies and Inflammatory Mediators in HealthcareWorkers and COVID-19 Patients
title_full_unstemmed Comparative Analysis of Circulating Levels of SARS-CoV-2 Antibodies and Inflammatory Mediators in HealthcareWorkers and COVID-19 Patients
title_sort Comparative Analysis of Circulating Levels of SARS-CoV-2 Antibodies and Inflammatory Mediators in HealthcareWorkers and COVID-19 Patients
author Pinto, Luzia Maria de Oliveira
author_facet Pinto, Luzia Maria de Oliveira
Solórzano, Victor Edgar Fiestas
Martins, Maria de Lourdes
Santos, Caroline Fernandes
Damasco, Paula Hesselberg
Siqueira, Marilda Agudo Mendonça Teixeira de
Dias, Helver Gonçalves
Pauvolid-Corrêa, Alex
Damasco, Paulo Vieira
Azeredo, Elzinandes Leal de
author_role author
author2 Solórzano, Victor Edgar Fiestas
Martins, Maria de Lourdes
Santos, Caroline Fernandes
Damasco, Paula Hesselberg
Siqueira, Marilda Agudo Mendonça Teixeira de
Dias, Helver Gonçalves
Pauvolid-Corrêa, Alex
Damasco, Paulo Vieira
Azeredo, Elzinandes Leal de
author2_role author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Pinto, Luzia Maria de Oliveira
Solórzano, Victor Edgar Fiestas
Martins, Maria de Lourdes
Santos, Caroline Fernandes
Damasco, Paula Hesselberg
Siqueira, Marilda Agudo Mendonça Teixeira de
Dias, Helver Gonçalves
Pauvolid-Corrêa, Alex
Damasco, Paulo Vieira
Azeredo, Elzinandes Leal de
dc.subject.other.en_US.fl_str_mv SARS-CoV-2
COVID-19
Profissionais de saúde
Anticorpos
Citocina
Quimiocinas
Pacientes
Brasil
topic SARS-CoV-2
COVID-19
Profissionais de saúde
Anticorpos
Citocina
Quimiocinas
Pacientes
Brasil
SARS-CoV-2
COVID-19
Healthcare workers
Antibodies
Cytokines
Chemokines
Brazil
Patients
dc.subject.en.en_US.fl_str_mv SARS-CoV-2
COVID-19
Healthcare workers
Antibodies
Cytokines
Chemokines
Brazil
Patients
description Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Imunologia Viral. Rio de Janeiro, RJ, Brasil.
publishDate 2022
dc.date.issued.fl_str_mv 2022
dc.date.accessioned.fl_str_mv 2023-01-10T17:33:09Z
dc.date.available.fl_str_mv 2023-01-10T17:33:09Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.citation.fl_str_mv PINTO, Luzia Maria de Oliveira et al. Comparative Analysis of Circulating Levels of SARS-CoV-2 Antibodies and Inflammatory Mediators in Healthcare Workers and COVID-19 Patients. Viruses, v. 14, 455, p. 1 - 19, Feb. 2022.
dc.identifier.uri.fl_str_mv https://www.arca.fiocruz.br/handle/icict/56423
dc.identifier.issn.en_US.fl_str_mv 1999-4915
dc.identifier.doi.none.fl_str_mv 10.3390/v14030455
identifier_str_mv PINTO, Luzia Maria de Oliveira et al. Comparative Analysis of Circulating Levels of SARS-CoV-2 Antibodies and Inflammatory Mediators in Healthcare Workers and COVID-19 Patients. Viruses, v. 14, 455, p. 1 - 19, Feb. 2022.
1999-4915
10.3390/v14030455
url https://www.arca.fiocruz.br/handle/icict/56423
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv MDPI
publisher.none.fl_str_mv MDPI
dc.source.none.fl_str_mv reponame:Repositório Institucional da FIOCRUZ (ARCA)
instname:Fundação Oswaldo Cruz (FIOCRUZ)
instacron:FIOCRUZ
instname_str Fundação Oswaldo Cruz (FIOCRUZ)
instacron_str FIOCRUZ
institution FIOCRUZ
reponame_str Repositório Institucional da FIOCRUZ (ARCA)
collection Repositório Institucional da FIOCRUZ (ARCA)
bitstream.url.fl_str_mv https://www.arca.fiocruz.br/bitstream/icict/56423/1/license.txt
https://www.arca.fiocruz.br/bitstream/icict/56423/2/LuziaPinto_AlexCorrea_etal_IOC_2022.pdf
bitstream.checksum.fl_str_mv 5a560609d32a3863062d77ff32785d58
c0938d3de6aa54a012207f05d31e884d
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
repository.name.fl_str_mv Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)
repository.mail.fl_str_mv repositorio.arca@fiocruz.br
_version_ 1798324883795476480